Pacifica Partners’s iShares Biotechnology ETF IBB Stock Holding History

Pacifica Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-240	Closed	-$32.4K	–	523
2024 Q2	$32.4K	Hold	240	–	–	0.01%	253
2024 Q1	$32.6K	Buy	240 +130	+118%	+$17.8K	0.01%	254
2023 Q4	$13.5K	Hold	110	–	–	0.01%	335
2023 Q3	$13.4K	Hold	110	–	–	0.01%	319
2023 Q2	$14K	Hold	110	–	–	0.01%	267
2023 Q1	$14.4K	Hold	110	–	–	0.01%	273
2022 Q4	$14.2K	Hold	110	–	–	0.01%	254
2022 Q3	$13K	Buy	110 +40	+57%	+$4.97K	0.01%	272
2022 Q2	$8K	Hold	70	–	–	0.01%	331
2022 Q1	$9K	Hold	70	–	–	0.01%	315
2021 Q4	$10K	Hold	70	–	–	0.01%	303
2021 Q3	$12K	Hold	70	–	–	0.01%	275
2021 Q2	$11K	Hold	70	–	–	0.01%	277
2021 Q1	$11K	Hold	70	–	–	0.01%	256
2020 Q4	$11K	Hold	70	–	–	0.01%	237
2020 Q3	$9K	Hold	70	–	–	0.01%	221
2020 Q2	$10K	Sell	70 -20	-22%	-$2.55K	0.01%	232
2020 Q1	$10K	Buy	+90	New	+$10.4K	0.01%	226

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Pacifica Partners's IBB Position: Q3 2024 in Review

Pacifica Partners sold out of iShares Biotechnology ETF (IBB) in Q3 2024, closing a stake of 240 shares — an estimated $32.4K sold.

Pacifica Partners first reported a position in IBB in Q1 2020 and held it in 18 quarters. The position peaked at $32.6K in Q1 2024. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

Pacifica Partners reported no remaining iShares Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
Pacifica Partners sold 240 iShares Biotechnology ETF shares in Q3 2024, an estimated $32.4K.
Pacifica Partners first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 18 quarters.
Pacifica Partners's iShares Biotechnology ETF position peaked at $32.6K in Q1 2024.
893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on Pacifica Partners's 13F filing for Q3 2024, filed 7 Oct 2024.